Olainfarm wins brand dispute with Grindeks
This article was originally published in Scrip
Executive Summary
A district court in Riga, Latvia, has withdrawn a temporary injunction for Olainfarm's cardiovascular product containing generic meldonium, which had been imposed on 28 July. The verdict was final with no right to appeal.